Andrzej Jakubowiak to T-Lymphocytes
This is a "connection" page, showing publications Andrzej Jakubowiak has written about T-Lymphocytes.
Connection Strength
0.068
-
Elranatamab in relapsed or refractory multiple myeloma: the MagnetisMM-1 phase 1 trial. Nat Med. 2023 10; 29(10):2570-2576.
Score: 0.036
-
Antibody and T cell responses to COVID-19 vaccination in patients receiving anticancer therapies. J Immunother Cancer. 2022 06; 10(6).
Score: 0.032